ORA-12541: TNS : pas de processus d'écoute
Titre de la technologie / Technology Title
Ajout de composés oestrogéniques ou d'un précurseur de l'oestradiol, le DHEA (ou son dérivé sulfaté le DHEA-sulfate), au traitement dopaminergique des patients parkinsoniens
Description / Description
The present invention relates to a method for treating the symptoms associated to a neurodegenerative disease in a patient. The method of the present invention comprises concomitantly administering to the patient a therapeutically effective amount of at least one of dehydroepiandrosterone and dehydroepiandrosterone-sulfate with a therapeutically effective amount of a dopamine precursor.
The present invention also relates to a pharmaceutical composition for treating the symptoms associated to a neurodegenerative disease and to a composition for use in the treatment of symptoms associated to a neurodegenerative disease. Composition comprises a therapeutically effective amount of at least one of dehydroepiandrosterone and dehydroepiandrosterone-sulfate with a therapeutically effective amount of a dopamine precursor.
The present invention further relates to the use of a composition in the manufacture of a medicament for the treatment of symptoms associated to a neurodegenerative disease, where the composition comprises a therapeutically effective amount of at least one of dehydroepiandrosterone and dehydroepiandrosterone-sulfate with a therapeutically effective amount of a dopamine precursor.
The present invention finally relates to the use of a composition for the treatment of symptoms associated to a neurodegenerative disease, where the composition comprises a therapeutically effective amount of at least one of dehydroepiandrosterone and dehydroepiandrosterone-sulfate with a therapeutically effective amount of a dopamine precursor.
Fiche descriptive / Fact sheet
Inventeur / Inventor
Contact / Contact
Champs(s) d'intérêt(s) / Industry segment(s)
Numéro de la technologie / File Number : 00539
ORA-12541: TNS : pas de processus d'écoute